공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 비마약성 진통제 시장(-2024년)

Non-opioid Pain Treatment: Global Markets to 2024

리서치사 BCC Research
발행일 2019년 12월 상품 코드 606202
페이지 정보 영문 165 Pages
가격
US $ 5,500 ₩ 6,300,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,560,000 PDF (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 9,072,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,504 ₩ 10,886,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 비마약성 진통제 시장(-2024년) Non-opioid Pain Treatment: Global Markets to 2024
발행일 : 2019년 12월 페이지 정보 : 영문 165 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 비마약성 진통제(Non-opioid Pain Treatment) 시장에 대해 조사했으며, 시장 정의 및 개요, 통증 및 통증 치료의 경위, 시장 성장에 대한 각종 영향요인 및 시장 기회 분석, 통증 치료에 대한 대체적 비마약성 요법의 각종 종류, 제품 부문·질환 부문·지역/주요 국가별 동향, 시장 규모 추이 및 예측, 특허 동향, 주요 기업 개요 등을 정리했습니다.

제1장 서론

제2장 요약 및 하이라이트

  • 시장 개요
  • 성장 촉진요인과 저해요인

제3장 시장 개요와 배경

  • 통증 및 통각수용의 정의
  • 통증 및 통증 치료의 역사
  • 생리학적 통증의 분류
  • 통증의 진단
  • 통증의 치료
  • 마약성 vs 비마약성 통증 관리
  • 마약성 진통제로 알려진 오피오이드
  • 전체 및 부분 작용제
  • 작용제-길항제
  • 마약성 통증 치료의 위험과 합병증
  • 통증 관리의 대체적 방법
  • 대체적 비마약성 요법
    • 의료 대마
    • 캡사이신 유래 화합물
    • 멘톨 함유 화합물
    • 오메가 3 지방산 함유 서플리먼트
    • 보툴리눔톡신(보톡스)
    • 기타
  • 대마에 의한 통증 치료의 확대
    • 의료 대마의 도입 : 세계 분석
    • 규제
    • 효과성
    • 역가 시험 및 검증 시험
  • 호스피스 케어
  • 완화 의료에 대한 접근
  • 완화 의료 요구의 평가
  • 시장 영향요인과 성장 지표
  • 인구동태 개요
  • 통증을 수반하는 증상의 발생률·유병률

제4장 시장 분석 및 예측 : 제품 부문별

  • 개요
  • 의료 대마
  • 캡사이신 유래 화합물
  • 멘톨 함유 화합물
  • 오메가 3 지방산 함유 서플리먼트
  • 보툴리눔톡신(보톡스)

제5장 시장 분석 및 예측 : 질환 부문별

  • 개요
  • 암성 통증
  • 신경성 통증
  • 정형외과/근골격계 통증
  • 기타

제6장 시장 분석 및 예측 : 지역 및 주요 국가별

  • 개요
  • 북미
  • 유럽, 중동 및 아프리카
  • 아시아태평양
  • 라틴아메리카

제7장 특허 분석

제8장 기업 개요

  • ALLERGAN PLC
  • APHRIA INC.
  • AURORA
  • BEDROCAN
  • CANOPY GROWTH CORP.
  • CARA THERAPEUTICS
  • CENTREXION THERAPEUTICS
  • CHT MEDICAL
  • CRONOS GROUP
  • GW PHARMACEUTICALS
  • MEDICAL MARIJUANA INC.
  • MEDROPHARM GMBH
  • PANAG PHARMA INC.
  • TILRAY
  • US WORLDMEDS LLC
  • VANWAY

제9장 부록 : 용어 및 정보 출처

KSM 20.01.09

List of Tables

  • Table A: Major Countries, by Region
  • Summary Table: Global Market for Non-opioid Pain Treatments, by Product Segment, Through 2024
    • Table 1: Physiological Effects of Pain
    • Table 2: United States Opioid Addiction and Abuse Statistics
    • Table 3: Global Opioid Addiction and Abuse Statistics
    • Table 4: List of Brand Name Extended-release and Long-acting Opioid Products Required to be Included in Opioid REMS, May 2017
    • Table 5: List of Generic Extended-release and Long-acting Opioid Products Required to be Included in Opioid REMS, May 2017
    • Table 6: List of Transmucosal Immediate-release Fentanyl Products Required to be Included in the TIRF REMS Access Program
    • Table 7: Adoption of Medical Cannabis, by Country (Age 15 and Over), 2017
    • Table 8: Medical Cannabis Programs, by U.S. State, 1998-2017
    • Table 9: Top Five U.S. States with Medical Cannabis Applications/Registrations
    • Table 10: Effectiveness of Fibromyalgia Treatments: Cannabis vs. Pharmaceutical Therapies
    • Table 11: Hospice Statistics, Patient Characteristics, 2009-2014
    • Table 12: Hospice Statistics, Patients, by Primary Diagnosis, 2009-2014
    • Table 13: Global Population, by Country/Region, Through 2024
    • Table 14: Global Population, Age 65+, by Country/Region, Through 2024
    • Table 15: Global Life Expectancy at Birth, by Country/Region, 1980, 2010 and 2020 Projections (Both Genders Combined)
    • Table 16: Global Non-opioid Pain Treatment Market, by Product Segment, Through 2024
    • Table 17: Global Market Shares of Non-opioid Pain Treatments, by Product Segment, 2018
    • Table 18: Selected Cannabis Clinical Trials for Pain Treatment, Through Nov. 30, 2018
    • Table 19: Global Medical Cannabis Pain Treatment Market, by Indication, Through 2024
    • Table 20: Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2018
    • Table 21: Selected Capsaicin-derived Clinical Trials for Pain Treatment, Through Nov. 30, 2019
    • Table 22: Global Capsaicin-derived Pain Treatment Market, by Indication, Through 2024
    • Table 23: Global Market Shares of Capsaicin-derived Pain Treatments, by Indication, 2018
    • Table 24: Clinical Trials on Menthol Containing Non-Opioid Pain Therapeutics for Diabetic Neuropathic Pain, Through Nov. 30, 2017
    • Table 25: Global Menthol-containing Pain Treatment Market, by Indication, Through 2024
    • Table 26: Selected Omega-3 Fatty Acid-containing Clinical Trials for Pain Treatment, Through Nov. 30, 2019
    • Table 27: Selected Omega-3 Fatty Acid-containing Clinical Trials for Pain Treatment, Through Nov. 30, 2019
    • Table 28: Global Omega-3 Fatty Acid-containing Pain Treatment Market, by Indication, Through 2024
    • Table 29: Global Market Shares of Omega-3 Fatty Acid-containing Pain Treatments, by Indication, 2018
    • Table 30: U.S. Market for Allergan's Botox, by Treatment Area, 2018
    • Table 31: Selected Botulinum Toxin Clinical Trials for Pain Treatment, Through Nov. 30, 2017
    • Table 32: Global Botulinum Toxin Pain Treatment Market, by Indication, Through 2024
    • Table 33: Global Market for Botulinum Toxin Pain Treatments, by Indication, 2018
    • Table 34: Global Non-opioid Pain Treatment Market, by Therapeutic Application, Through 2024
    • Table 35: Global Market Shares of Non-opioid Pain Treatments, by Therapeutic Application, 2018
    • Table 36: Global Non-opioid Cancer Pain Treatment Market, by Product Segment, Through 2024
    • Table 37: Global Market Shares of Non-opioid Cancer Pain Treatments, by Product Segment, 2018
    • Table 38: Global Market Shares of Non-opioid Cancer Pain Treatments, by Cancer Type, 2018
    • Table 39: Global Non-opioid Neuropathic Pain Treatment Market, by Product Segment, Through 2024
    • Table 40: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Product Segment, 2018
    • Table 41: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Disease/Disorder Type, 2018
    • Table 42: Global Non-opioid Orthopedic/Musculoskeletal Pain Treatment Market, by Product Segment, Through 2024
    • Table 43: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Product Segment, 2018
    • Table 44: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Disease/Disorder Type, 2018
    • Table 45: Global Market for Other Non-opioid Pain Treatments, by Product Segment, Through 2024
    • Table 46: Global Market Shares of Other Non-opioid Pain Treatments, by Product Segment, 2018
    • Table 47: Global Market Shares of Other Non-opioid Pain Treatments, by Disease/Disorder Type, 2018
    • Table 48: Global Non-opioid Pain Treatment Market, by Region, Through 2024
    • Table 49: Global Market Shares of Non-opioid Pain Treatments, by Region, 2018
    • Table 50: Regional Grouping: Countries, by Region
    • Table 51: North American Non-opioid Pain Treatment Market, by Country, Through 2024
    • Table 52: EMEA Non-opioid Pain Treatment Market, by Country, Through 2024
    • Table 53: Asia-Pacific Non-opioid Pain Treatment Market, by Country, Through 2024
    • Table 54: Latin American Non-opioid Pain Treatment Market, by Country, Through 2024
    • Table 55: U.S. Patents Related to Medical Cannabis, by Type, Through 2018
    • Table 56: U.S. Patents on Medical Cannabis Technologies, by Type, Through 2018
    • Table 57: Notable U.S. Patents Related to Medical Cannabis, by Company, Through 2018
    • Table 58: List of U.S. Patents Related to Medical Cannabis, July 2017-Nov. 2017
    • Table 59: Notable Developments in Non-opioid Pain Relief, 2000-2017
    • Table 60: Glossary of Terms Used in Non-opioid Pain Treatment
    • Table 61: Global Pain Societies and Organizations
    • Table 62: Report Sources

List of Figures

  • Summary Figure: Global Market for Non-opioid Pain Treatments, by Product Segment, 2018-2024
    • Figure 1: Non-opioid Pain Management Market Drivers and Restraints
    • Figure 2: Pain Management Techniques
    • Figure 3: Total Hospice Patients Served, by Year, 2009-2014
    • Figure 4: Distribution of Causes of Mortality and Potential Need for Palliative Care, 2018
    • Figure 5: Global Population, by Country/Region, 2019 and 2024
    • Figure 6: Global Population Age 65+, by Country/Region, 2019 and 2024
    • Figure 7: Global Life Expectancy at Birth, by Country/Region, 1980, 2010 and 2020 Projections (Both Genders Combined)
    • Figure 8: Global Non-opioid Pain Treatment Market, by Product Segment, 2018-2024
    • Figure 9: Global Market Shares of Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 10: Global Market Shares of Medical Cannabis: Pain vs. All Other Uses, 2018
    • Figure 11: Global Medical Cannabis Pain Treatment Market, by Indication, 2018-2024
    • Figure 12: Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2018
    • Figure 13: Global Capsaicin-derived Pain Treatment Market, by Indication, 2018-2024
    • Figure 14: Global Market Shares of Capsaicin-derived Pain Treatments, by Indication, 2018
    • Figure 15: Global Menthol-containing Pain Treatment Market, by Indication, 2018-2024
    • Figure 16: Global Market Shares of Menthol-containing Pain Treatments, by Indication, 2018
    • Figure 17: Global Omega-3 Fatty Acid-containing Pain Treatment Market, by Indication, 2018-2024
    • Figure 18: Global Market Shares of Omega-3 Fatty Acid-containing Pain Treatments, by Indication, 2018
    • Figure 19: Global Botulinum Toxin Pain Treatment Market, by Indication, 2018-2024
    • Figure 20: Global Market Shares of Botulinum Toxin Pain Treatments, by Indication, 2018
    • Figure 21: Global Non-opioid Pain Treatment Market, by Therapeutic Application, 2019-2024
    • Figure 22: Global Market Shares of Non-opioid Pain Treatments, by Therapeutic Application, 2018
    • Figure 23: Global Non-opioid Cancer Pain Treatment Market, by Product Segment, 2018-2024
    • Figure 24: Global Market Shares of Non-opioid Cancer Pain Treatments, by Product Segment, 2018
    • Figure 25: Global Market Shares of Non-opioid Cancer Pain Treatments, by Cancer Type, 2018
    • Figure 26: Global Non-opioid Neuropathic Pain Treatment Market, by Product Segment, 2018-2024
    • Figure 27: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Product Segment, 2018
    • Figure 28: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Disease/Disorder Type, 2018
    • Figure 29: Global Non-opioid Orthopedic/Musculoskeletal Pain Treatment Market, by Product Segment, 2018-2024
    • Figure 30: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Product Segment, 2018
    • Figure 31: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Disease/Disorder Type, 2018
    • Figure 32: Global Market for Other Non-opioid Pain Treatments, by Product Segment, 2018-2024
    • Figure 33: Global Market Shares of Other Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 34: Global Market Shares of Other Non-opioid Pain Treatments, by Disease/Disorder Type, 2018
    • Figure 35: Global Non-opioid Pain Treatment Market, by Region, 2018-2024
    • Figure 36: Global Market Shares of Non-opioid Pain Treatments, by Region, 2018
    • Figure 37: North American Non-opioid Pain Treatment Market, by Country, 2018-2024
    • Figure 38: North American Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
    • Figure 39: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 40: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 41: U.S. Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 42: U.S. Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 43: EMEA Non-opioid Pain Treatment Market, by Country, 2018-2024
    • Figure 44: EMEA Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
    • Figure 45: French Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 46: French Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 47: German Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 48: German Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 49: Italian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 50: Italian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 51: Russian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 52: Russian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 53: Spanish Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 54: Spanish Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 55: U.K. Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 56: U.K. Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 57: Asia-Pacific Non-opioid Pain Treatment Market, by Country, 2018-2024
    • Figure 58: Asia-Pacific Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
    • Figure 59: Australia/New Zealand's Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 60: Australia/New Zealand's Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 61: Chinese Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 62: Chinese Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 63: Japanese Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 64: Japanese Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 65: Latin American Non-opioid Pain Treatment Market, by Country, 2018-2024
    • Figure 66: Latin American Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
    • Figure 67: Argentinean Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 68: Argentinean Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 69: Brazilian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 70: Brazilian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 71: Mexican Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
    • Figure 72: Mexican Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
    • Figure 73: Total U.S. Patents on Non-opioid Pain Treatments, by Type, Through 2018
    • Figure 74: Shares of U.S. Patents Related to Medical Cannabis, by Type, Through 2018
    • Figure 75: Shares of U.S. Patents on Medical Cannabis Technologies, by Type, Through 2018

Report Highlights:

The global market for non-opioid pain treatments should grow from $13.8 billion in 2019 to $31.8 billion by 2024 at a compound annual growth rate (CAGR) of 18.3% for the period of 2019-2024.

Medical cannabis non-opioid pain treatments market should grow from $9.4 billion in 2019 to reach $22.2 billion by 2024 at a CAGR of 18.8% for the period of 2019-2024.

Capsaicin-derived non-opioid pain treatments market should grow from $438.0 million in 2019 to reach $1.1 billion by 2024 at a CAGR of 20.4% for the period of 2019-2024.

Report Scope:

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies five general product segments for Non-opioid treatment of pain -

  • Medical cannabis treatments.
  • Capsaicin-derived treatments.
  • Menthol-containing treatments.
  • Omega 3 fatty acid-containing treatments.
  • Botulinum toxins.

Within the segment several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including -

  • Arthritis.
  • Cancer-brain, breast, colorectal, leukemia/lymphoma, melanoma, prostate, others.
  • Dental.
  • Epilepsy.
  • Fibromyalgia.
  • Migraine.
  • Multiple sclerosis.
  • Surgical.

A regional analysis of these product segments is also provided, including the specific countries listed below and including countries not listed as a "rest of the world" market.

  • Argentina.
  • Australia/New Zealand.
  • Brazil.
  • Canada.
  • China.
  • France.
  • Germany.
  • Italy.
  • Japan.
  • Mexico.
  • Russia.
  • Spain.
  • United Kingdom.
  • United States.

Each market segment provides detailed information based on product categories, product use, current market value and forecasts.

Not covered in the report are drugs or devices that are considered "conventional" in professional treatment guidelines that are due to either controversial issues such as those with medical cannabis or those that are not commonly prescribed or recommended due to a lack of clinical data, education or other factors.

Report Includes:

  • 44 data tables and 19 additional tables
  • An overview of the global market for Non-opioid pain treatments
  • Analyses of global market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Description of products included in this market, and a detailed analysis of the markets and market opportunities
  • Information on significant products categories, issues and trends, market influences, regulatory issues and other information affecting the pain management industry
  • Briefing about major drivers and regional dynamics of the market and current trends within the industry
  • Comprehensive profiles of major vendors in the market, including Allergan PLC, Canopy Growth Corp., Medical Marijuana Inc., Panag Pharma Inc., and Tilray

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Market Overview
  • Drivers and Restraints

Chapter 3: Market Overview and Background

  • Definition of Pain and Nociception
    • Pain
    • Nociception
  • History of Pain and Pain Treatment
  • Types of Pain
    • Acute Pain
    • Chronic Pain
  • Physiological Pain Classifications
  • How Pain is Diagnosed
  • How Pain is Treated
  • Opioid vs. Non-opioid Pain Control
    • Opioids, also Known as Narcotic Analgesics
  • Full and Partial Agonists
  • Agonist-Antagonists
  • Risk and Complications in Opioid Pain Treatment
    • Addiction and Abuse
    • Challenges of Breakthrough Pain Control
  • Alternative Methods of Pain Management
  • Alternative Non-opioid Therapies for Treating Pain
    • Medical Cannabis
    • Capsaicin-derived Compound
    • Menthol-containing Compound
    • Omega 3 Fatty Acid-containing Supplements
    • Botulinum Toxins (OnabotulinumtoxinA/RimabotulinumtoxinB)
    • Others
  • Growing Trend in Cannabis Treatment for Pain
    • Adoption of Medical Cannabis: A Global Analysis
  • Laws and Legalization Trends
  • Claims in Effectiveness
  • Potency and Validation Testing Trends
    • Hospice Care
  • Access to Palliative Care Around the World
    • Assessing the Need for Palliative Care
  • Market Influences and Indicators of Growth
    • Demographic Overview
    • Incidence and Prevalence of Conditions with Pain Symptoms

Chapter 4: Market Breakdown by Product Segment

  • Overview
  • Medical Cannabis
  • Capsaicin-derived Therapies
  • Menthol-containing Therapies
  • Omega-3 Fatty Acid-containing Therapies
  • Botulinum Toxin Treatments

Chapter 5: Market Breakdown by Therapeutic Application

  • Overview
  • Alternative Non-opioid Cancer Pain Treatment
  • Alternative Non-opioid Neuropathic Pain Treatment
  • Alternative Non-opioid Orthopedic/Musculoskeletal Pain Treatments
  • Other Alternative Non-Opioid Pain Treatments

Chapter 6: Market Breakdown by Region

  • Overview
    • Regional Groupings
  • North America
    • North America: Pioneer in the Medicinal Cannabis Industry
    • Canada
    • United States
  • EMEA
    • France
    • Germany
    • Italy
    • Russia
    • Spain
    • United Kingdom
  • Asia-Pacific
    • Australia/New Zealand
    • China
    • Japan
  • Latin America
    • Argentina
    • Brazil
    • Mexico

Chapter 7: Patent Analysis

  • Patent Analysis Overview
  • Non-opioid Pain Relief Categories
  • Medical Cannabis
    • Technologies
    • Cannabis Patent Review by Year
    • Patent Review by Company
    • Patent Review by Assignee

Chapter 8: Company Profiles

  • ALLERGAN PLC
  • APHRIA INC.
  • AURORA
  • BEDROCAN
  • CANOPY GROWTH CORP.
  • CARA THERAPEUTICS
  • CENTREXION THERAPEUTICS
  • CHT MEDICAL
  • CRONOS GROUP
  • GW PHARMACEUTICALS
  • MEDICAL MARIJUANA INC.
  • MEDROPHARM GMBH
  • PANAG PHARMA INC.
  • TILRAY
  • US WORLDMEDS LLC
  • VANWAY

Chapter 9: Appendix: Terminology and Sources of Information

Back to Top
전화 문의
F A Q